Pulmatrix Appoints Mark Iwicki Chairman of the Board

LEXINGTON, Mass., Dec. 8, 2015 -- (Healthcare Sales & Marketing Network) -- Pulmatrix, Inc. (PULM), a biopharmaceutical company developing inhaled therapies for pulmonary disease, today announced the appointment of Mark Iwicki as chairman of its board of ... Biopharmaceuticals, Drug Delivery, PersonnelPulmatrix, iSPERSE, cystic fibrosis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news